Literature DB >> 12421824

Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I.

Alessia Andreola1, Vittorio Bellotti, Sofia Giorgetti, Palma Mangione, Laura Obici, Monica Stoppini, Jaume Torres, Enrico Monzani, Giampaolo Merlini, Margaret Sunde.   

Abstract

The N-terminal portion of apolipoprotein A-I corresponding to the first 93 residues has been identified as the main component of apolipoprotein A-I fibrils in a form of systemic amyloidosis. We have been able to characterize the process of conformational switching and fibrillogenesis in this fragment of apolipoprotein A-I purified directly from ex vivo amyloid material. The peptide exists in an unstructured form in aqueous solution at neutral pH. The acidification of the solution provokes a collapse into a more compact, intermediate state and the transient appearance of a helical conformation that rapidly converts to a stable, mainly beta-structure in the fibrils. The transition from helical to sheet structure occurs concomitantly with peptide self-aggregation, and fibrils are detected after 72 h. The alpha-helical conformation is induced by the addition of trifluoroethanol and phospholipids. Interaction of the amyloidogenic polypeptide with phospholipids prevents the switching from helical to beta-sheet form and inhibits fibril formation. The secondary structure propensity of the apolipoprotein A-I fragment appears poised between helix and the beta-sheet. These findings reinforce the idea of a delicate balance between natively stabilizing interactions and fatally stabilizing interactions and stress the importance of cellular localization and environment in the maintenance of protein conformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421824     DOI: 10.1074/jbc.M204801200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.

Authors:  Martino Calamai; Fabrizio Chiti; Christopher M Dobson
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

Review 2.  Disorder-to-order conformational transitions in protein structure and its relationship to disease.

Authors:  Paola Mendoza-Espinosa; Victor García-González; Abel Moreno; Rolando Castillo; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2009-04-09       Impact factor: 3.396

3.  Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.

Authors:  Chiharu Mizuguchi; Fuka Ogata; Shiho Mikawa; Kohei Tsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

4.  NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.

Authors:  Timothy M Ryan; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

5.  Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.

Authors:  Gary K L Chan; Andrzej Witkowski; Donald L Gantz; Tianqi O Zhang; Martin T Zanni; Shobini Jayaraman; Giorgio Cavigiolio
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

6.  Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.

Authors:  Emi Adachi; Hiroyuki Nakajima; Chiharu Mizuguchi; Padmaja Dhanasekaran; Hiroyuki Kawashima; Kohjiro Nagao; Kenichi Akaji; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2012-12-11       Impact factor: 5.157

7.  Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.

Authors:  Chiharu Mizuguchi; Miho Nakagawa; Norihiro Namba; Misae Sakai; Naoko Kurimitsu; Ayane Suzuki; Kaho Fujita; Sayaka Horiuchi; Teruhiko Baba; Takashi Ohgita; Kazuchika Nishitsuji; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

8.  Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.

Authors:  Daria Maria Monti; Fulvio Guglielmi; Maria Monti; Flora Cozzolino; Silvia Torrassa; Annalisa Relini; Piero Pucci; Angela Arciello; Renata Piccoli
Journal:  Eur Biophys J       Date:  2010-02-25       Impact factor: 1.733

9.  Conformational preferences of a 14-residue fibrillogenic peptide from acetylcholinesterase.

Authors:  Ranjit Vijayan; Philip C Biggin
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

10.  EPR assessment of protein sites for incorporation of Gd(III) MRI contrast labels.

Authors:  Jens O Lagerstedt; Jitka Petrlova; Silvia Hilt; Antonin Marek; Youngran Chung; Renuka Sriram; Madhu S Budamagunta; Jean F Desreux; David Thonon; Thomas Jue; Alex I Smirnov; John C Voss
Journal:  Contrast Media Mol Imaging       Date:  2013 May-Jun       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.